Ingolf Cascorbi

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Venues

Clinical pharmacology and therapeutics

Expert opinion on drug metabolism & toxicology

Scientific reports

eLife

Kiel University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kiel University Jun 01 2004

Germany

Professor, Director :: Institute of Experimental and Clinical Pharmacology

University of Greifswald Apr 01 2000 - May 31 2004

Germany

Professor :: Institute of Pharmacology

Charite Universitatsmedizin Berlin Aug 01 1993 - Feb 29 2000

Germany

Research Assistant :: Institute of Clinical Pharmacology

Charité Universitätsmedizin Berlin Campus Benjamin Franklin Feb 15 1993 - Jul 31 1993

Germany

Medical Intern :: Institute of Clinical Pharmacology

Freie Universität Berlin Sep 01 1985 - Dec 31 1992

Germany

Research Assistant :: Institute of Biochemistry and Molecular Biologie

Publications

Anne Kasten, Ingolf Cascorbi
Understanding the impact of ABCG2 polymorphisms on drug pharmacokinetics: focus on rosuvastatin and allopurinol. Expert opinion on drug metabolism & toxicology 20 (6) (2024)
Leonardo Vinícius Monteiro de Assis, Lisbeth Harder, José Thalles Lacerda, Rex Parsons, Meike Kaehler, Ingolf Cascorbi, Inga Nagel, Oliver Rawashdeh, Jens Mittag, Henrik Oster
Tuning of liver circadian transcriptome rhythms by thyroid hormone state in male mice. Scientific reports 14 (1) (2024)
Ruwen Böhm, Henrike Bruckmueller, Stefan Oswald, Matthias Hübenthal, Meike Kaehler, Lena Ehmke, Jan Höcker, Werner Siegmund, Andre Franke, Ingolf Cascorbi
Phenotype-Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism. Clinical pharmacology and therapeutics (2024)
Ruwen Böhm, Henrike Bruckmueller, Stefan Oswald, Matthias Hübenthal, Meike Kaehler, Lena Ehmke, Jan Höcker, Werner Siegmund, Andre Franke, Ingolf Cascorbi
Phenotype-Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism. Clinical pharmacology and therapeutics 116 (1) (2024)
Christin Krause, Jan H Britsemmer, Miriam Bernecker, Anna Molenaar, Natalie Taege, Nuria Lopez-Alcantara, Cathleen Geißler, Meike Kaehler, Katharina Iben, Anna Judycka, Jonas Wagner, Stefan Wolter, Oliver Mann, Paul Pfluger, Ingolf Cascorbi, Hendrik Lehnert, Kerstin Stemmer, Sonja C Schriever, Henriette Kirchner
Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity. eLife 12 (2024)
Anne Kasten, Ingolf Cascorbi
Understanding the impact of ABCG2 Polymorphisms on Drug Pharmacokinetics:Focus on rosuvastatin and allopurinol. Expert opinion on drug metabolism & toxicology (2024)
Anne Kasten, Ingolf Cascorbi
Understanding the impact of ABCG2 polymorphisms on drug pharmacokinetics: focus on rosuvastatin and allopurinol. Expert opinion on drug metabolism & toxicology (2024)
Christin Krause, Jan H Britsemmer, Miriam Bernecker, Anna Molenaar, Natalie Taege, Nuria Lopez-Alcantara, Cathleen Geißler, Meike Kaehler, Katharina Iben, Anna Judycka, Jonas Wagner, Stefan Wolter, Oliver Mann, Paul Pfluger, Ingolf Cascorbi, Hendrik Lehnert, Kerstin Stemmer, Sonja C Schriever, Henriette Kirchner
Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity. eLife 12 (2024)
Leonardo Vinícius Monteiro de Assis, Lisbeth Harder, José Thalles Lacerda, Rex Parsons, Meike Kaehler, Ingolf Cascorbi, Inga Nagel, Oliver Rawashdeh, Jens Mittag, Henrik Oster
Tuning of liver circadian transcriptome rhythms by thyroid hormone state in male mice. Scientific reports 14 (1) (2024)
Christin Krause, Jan H Britsemmer, Miriam Bernecker, Anna Molenaar, Natalie Taege, Nuria Lopez-Alcantara, Cathleen Geißler, Meike Kaehler, Katharina Iben, Anna Judycka, Jonas Wagner, Stefan Wolter, Oliver Mann, Paul Pfluger, Ingolf Cascorbi, Hendrik Lehnert, Kerstin Stemmer, Sonja C Schriever, Henriette Kirchner
Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity. eLife 12 (2024)
Anne Kasten, Ingolf Cascorbi
Understanding the impact of ABCG2 polymorphisms on drug pharmacokinetics: focus on rosuvastatin and allopurinol. Expert opinion on drug metabolism & toxicology 20 (6) (2024)
Ingolf Cascorbi
Why is There Still Debate About Recommending DPYD-Testing Before Fluoropyrimidine Treatment? Clinical pharmacology and therapeutics 114 (4) (2023)
Ingolf Cascorbi
Clinical Pharmacology of Cannabinoid Therapeutics: Drug Interactions and Side Effects. Clinical pharmacology and therapeutics 114 (5) (2023)
Ruwen Böhm, Claudia Bulin, Vicki Waetzig, Ingolf Cascorbi, Hans-Joachim Klein, Thomas Herdegen
Pharmacovigilance-based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections. British journal of clinical pharmacology 87 (11) (2021)
Charles Awortwe, Henrike Bruckmueller, Meike Kaehler, Ingolf Cascorbi
Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux Transporters. Molecular pharmaceutics 18 (4) (2021)
Theresa Klümper, Henrike Bruckmueller, Tobias Diewock, Meike Kaehler, Sierk Haenisch, Christiane Pott, Oliver Bruhn, Ingolf Cascorbi
Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance. Experimental hematology & oncology 9 (2020)
Oliver Bruhn, Marie Lindsay, Friederike Wiebel, Meike Kaehler, Inga Nagel, Ruwen Böhm, Christian Röder, Ingolf Cascorbi
Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA Regulation. Molecular pharmacology 97 (2) (2019)
Susanne Brueck, Henrike Bruckmueller, Danilo Wegner, Diana Busch, Paul Martin, Stefan Oswald, Ingolf Cascorbi, Werner Siegmund
Transcriptional and Post-Transcriptional Regulation of Duodenal P-Glycoprotein and MRP2 in Healthy Human Subjects after Chronic Treatment with Rifampin and Carbamazepine. Molecular pharmaceutics 16 (9) (2019)
Elizabeth Abou Diwan, Ralph I Zeitoun, Lea Abou Haidar, Ingolf Cascorbi, Nathalie Khoueiry Zgheib
Implementation and obstacles of pharmacogenetics in clinical practice: An international survey. British journal of clinical pharmacology 85 (9) (2019)
Nasir Ali Afsar, Henrike Bruckmueller, Anneke Nina Werk, Muhammad Kashif Nisar, H R Ahmad, Ingolf Cascorbi
Implications of genetic variation of common Drug Metabolizing Enzymes and ABC Transporters among the Pakistani Population. Scientific reports 9 (1) (2019)
Henrike Bruckmueller, Paul Martin, Meike Kähler, Sierk Haenisch, Marek Ostrowski, Marek Drozdzik, Werner Siegmund, Ingolf Cascorbi, Stefan Oswald
Clinically Relevant Multidrug Transporters Are Regulated by microRNAs along the Human Intestine. Molecular pharmaceutics 14 (7) (2017)
Inga Nagel, Marius Bartels, Johannes Duell, Hans-Heinrich Oberg, Sandra Ussat, Henrike Bruckmueller, Oliver Gerhard Ottmann, Heike Pfeifer, Heiko Trautmann, Nicola Gökbuget, Almuth Caliebe, Dieter Kabelitz, Michael Kneba, Heinz-August Horst, Dieter Hoelzer, Max S Topp, Ingolf Cascorbi, Reiner Siebert, Monika Brüggemann
Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy. Blood 130 (18) (2017)

Ingolf Cascorbi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ingolf Cascorbi